Edition:
United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.08CNY
15 Dec 2017
Change (% chg)

¥-0.05 (-0.70%)
Prev Close
¥7.13
Open
¥7.12
Day's High
¥7.17
Day's Low
¥7.06
Volume
3,523,530
Avg. Vol
13,368,583
52-wk High
¥8.00
52-wk Low
¥6.42

Chart for

About

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.96
Market Cap(Mil.): ¥17,901.51
Shares Outstanding(Mil.): 2,510.73
Dividend: 0.12
Yield (%): 1.68

Financials

  Industry Sector
P/E (TTM): -- 32.07 15.47
EPS (TTM): -- -- --
ROI: -- 15.07 33.71
ROE: -- 16.57 16.38

BRIEF-Zhejiang CONBA Pharmaceutical's 9-month net profit up 34.9 pct y/y

* Says 9-month net profit up 34.9 percent y/y at 607.1 million yuan ($91.74 million)

Oct 17 2017

BRIEF-Zhejiang Conba Pharmaceutical gets approval to issue 1.5 bln yuan medium-term notes

* Says it gets approval to issue 1.5 billion yuan ($228.81 million) medium-term notes

Sep 18 2017

BRIEF-Jinyuan Cement issues 119.4 mln shares and raises 1.21 bln yuan through private placement

* Says it issued 119.4 million shares and raised 1.21 billion yuan through private placement

Aug 18 2017

BRIEF-Zhejiang Conba Pharmaceutical's H1 net profit up 25.2 pct y/y

* Says H1 net profit up 25.2 percent y/y at 384.6 million yuan ($57.66 million)

Aug 14 2017

BRIEF-Zhejiang CONBA Pharmaceutical unit received approval for drug clinical trials

* Says its controlling unit has been granted approval for drug clinical trials for pirfenidone tablets issued by china food and drug administration

Jul 27 2017

BRIEF-Zhejiang CONBA Pharma's prelim H1 profit up 25.3 pct y/y

* Says preliminary H1 net profit up 25.3 percent y/y at 384.9 million yuan ($56.61 million)

Jul 11 2017

BRIEF-Zhejiang Conba Pharmaceutical's controlling shareholder to add up to 2 pct stake in next 6 months

* Says its controlling shareholder plans to add up to 2 percent stake in next 6 months

Jun 19 2017

Earnings vs. Estimates